We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MyoKardia Inc | NASDAQ:MYOK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 224.91 | 224.42 | 224.91 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * GIANAKAKOS ANASTASIOS | 2. Issuer Name and Ticker or Trading Symbol MyoKardia, Inc. [ MYOK ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President and CEO |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 5/11/2020 | S(1) | 600 | D | $98.6883 (2) | 63522 (3) | D | |||
Common Stock | 5/11/2020 | S(1) | 1700 | D | $100.5056 (4) | 61822 | D | |||
Common Stock | 5/11/2020 | S(1) | 18581 | D | $101.9044 (5) | 43241 | D | |||
Common Stock | 5/11/2020 | S(1) | 3519 | D | $102.5635 (6) | 39722 | D | |||
Common Stock | 5/11/2020 | S(1) | 600 | D | $103.33 (7) | 39122 | D | |||
Common Stock | 129407 | I | By Reporting Person's Trust 2 (8) | |||||||
Common Stock | 300000 | I | By Reporting Person's Trust 4 | |||||||
Common Stock | 7000 (9) | I | By Reporting Person's Trust 5 | |||||||
Common Stock | 10000 (10) | I | By Reporting Person's Trust 6 | |||||||
Common Stock | 53087 | I | By Trust 1 | |||||||
Common Stock | 53087 | I | By Trust 2 | |||||||
Common Stock | 53087 | I | By Trust 3 |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
GIANAKAKOS ANASTASIOS C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE, CA 94005 | X | President and CEO |
Signatures | ||
/s/ Cynthia Ladd, as Attorney-in-Fact | 5/13/2020 | |
**Signature of Reporting Person | Date |
1 Year MyoKardia Chart |
1 Month MyoKardia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions